Starpharma Holdings Limited (ASX:SPL – Get Free Report) insider Robert Thomas purchased 200,000 shares of Starpharma stock in a transaction dated Wednesday, October 23rd. The shares were purchased at an average cost of A$0.09 ($0.06) per share, for a total transaction of A$18,600.00 ($12,236.84).
Starpharma Price Performance
The company has a current ratio of 4.94, a quick ratio of 5.65 and a debt-to-equity ratio of 12.55.
About Starpharma
Featured Articles
- Five stocks we like better than Starpharma
- Comparing and Trading High PE Ratio Stocks
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- CD Calculator: Certificate of Deposit Calculator
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.